We offer expert support in dose escalation studies to identify the maximum tolerated dose (MTD) and establish safe therapeutic ranges. Our team uses stepwise escalation models and PK/PD simulations to guide dosing decisions and ensure patient safety.
At Althian, we understand the critical role late-phase clinical trials play in generating robust evidence that drives informed healthcare decisions. Our expert team is committed to executing rigorous, efficient trials while upholding the highest standards of data integrity and participant safety.
Look no further than Althian, a leading company specializing in a wide range of clinical research services.